STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Xeris Biopharma Holdings, Inc.
XERS
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$1.38
+16.2%
Net Income/Share
$-0.37
+17.4%
Operating CF/Share
$-0.25
+26.2%
Free CF/Share
$-0.26
+28.0%
Cash/Share
$0.49
-7.3%
Book Value/Share
$-0.20
-309.6%
Tangible Book/Share
$-1.03
-1.9%
Equity/Share
$-0.20
-309.6%
Interest Debt/Share
$2.08
+11.7%
Valuation
Market Cap
$497.56M
+53.8%
Enterprise Value
$697.39M
+43.7%
P/E Ratio
-9.07
-74.6%
P/S Ratio
2.45
+24.1%
P/OCF Ratio
-13.45
-95.5%
P/FCF Ratio
-13.15
-100.3%
P/B Ratio
-16.80
+64.8%
P/TB Ratio
-16.80
+64.8%
EV/Sales
3.43
+16.0%
EV/EBITDA
-49.83
-143.7%
Profitability
Earnings Yield
-11.02%
+42.7%
FCF Yield
-7.61%
+50.1%
ROE
185.16%
-79.8%
ROIC
-13.25%
+29.1%
Return on Tangible Assets
-27.24%
+16.9%
Capital Allocation
CapEx/OCF
-2.35%
+51.2%
CapEx/Revenue
0.43%
-69.0%
CapEx/Depreciation
0.07
-60.0%
SBC/Revenue
9.04%
+38.3%
Balance Sheet
Debt/Equity
-9.17
+72.9%
Debt/Assets
0.84
+18.3%
Net Debt/EBITDA
-14.28
-109.5%
Current Ratio
1.67
+1.7%
Interest Coverage
-1.01x
+38.7%
Income Quality
0.67
-10.7%
Efficiency
Days Sales Outstanding
73 days
-16.8%
Days Payables Outstanding
23 days
-84.6%
Days Inventory
477 days
-3.5%
Receivables Turnover
5.02x
+20.2%
Payables Turnover
16.08x
+549.4%
Inventory Turnover
0.76x
+3.7%
Special Valuations
Graham Number
--
Graham Net-Net
$-1.54
-2.2%